Technology/Technique |
Imaging |
Imaging |
Traditional Blood (detect CTC) & Tissue Biopsy study |
Advanced - Blood Based study |
Location detection |
Precise location for Lesions greater than a certain size |
Precise location for Lesions greater than a certain size |
No location; indicates ONLY Presence of cancer in body |
Location at organ level for all tumour sizes |
Activity Level detection |
Yes for ONLY visible lesions; not macro |
|
|
Yes @ Macro Level; not at lesion level |
Size |
For large lesions |
For large lesions |
|
Yes @ Macro Level |
Detection @ Stage of cancer |
Stages 1b, 2, 3, 4 only for solid cancers |
Stages 1b, 2, 3, 4 only for solid cancers |
Stages 1, 2, 3, 4 for few cancers only; subject to false negatives |
Stages 1, 2, 3, 4 & earlier; Applies for all cancer types |
Frequency Limit |
Once in 6-8 months |
Once in 6-8 months |
Blood test - Unlimited; Tissue biopsies - Limited |
Unlimited |
Drawbacks of PET, CT, & Liq Biopsy over Tzar Labs |
Hazardous |
Radiation Equals ~ 70,000 xrays |
Radiation Equals ~ 4000 xrays |
Blood test - Not Hazardous; Biopsies - Highly Invasive |
Non-Hazardous |
Non-Carcinogenic |
|
|
|
|
Cancer types |
Only applies to solid tumors NOT blood |
Only applies to solid tumors NOT blood |
Applies to Solid & Blood; but not relevant in many cancer types |
All Cancers - Applies to Solid & Blood |
Detection strengths |
Stage 1A cannot be detected |
Stage 1A cannot be detected |
Not detected until shedding begins in Stage 2; History of False Negatives |
Detected @ all stages including Pre - cancer (Before Stage-1); highly accurate |
Scope |
Diagnostic |
Diagnostic |
Diagnostic |
Prognostic + Diagnostic |
Post Manifestation of Tumour |
Post Manifestation of Tumour |
Post Manifestation of Tumour |
Post + Pre Manifestation of tumour |